4-Iodo-1-methyl-1h-pyrazole-5-carbonitrile, 95.0%, 250mg

(R)-2-Acetamido-2-phenylacetic acid, 95.0%, 5g

(S)-tert-Butyl 1-isopropylpyrrolidin-3-ylcarbamate, 95.0%, 1g

1-Butanol, min. 99.5%, for synthesis, 2.5 L, glass packaging

trans-Cinnamonitrile, 95.0%, 100g

Quinuclidine hydrochloride, 95+%, 250mg

Ethyl 2,2-difluoropent-4-enoate, 95.0%, 1g

2-Bromo-3-(trifluoromethyl)phenol, 95.0%, 25g

N-(3-Triethoxysilylpropyl)gluconamide, 30% in ethanol, 95%, 100g

4-(2-Hydroxyethoxy)benzaldehyde, 95.0%, 1g

fmoc-b-Homoaspartic acid (otbu), 95.0%, 5g

5-Amino-2-chloronicotinonitrile, 95.0%, 1g

2-[4-(Pyrimidin-2-yl)piperazin-1-yl]pyrimidine, 95%, 250mg